Evidence map›Paper›PMID 39154304›Full record

ArticleAnnals of nuclear medicine2024

SPECT/CT imaging: quantifying

Xiaoguang Hou, Yibo He, Guobing Liu, Shuguang Chen, Hongcheng Shi

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaoguang Hou *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
Yibo He *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
Guobing LiuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
Shuguang ChenDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. chen.shuguang@zs-hospital.sh.cn.
Hongcheng ShiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. shi.hongcheng@zs-hospital.sh.cn.

Funding

Chinese National Key Clinical Specialty Program YWP2022-007Supported Programme of the Siemens Healthineers Ltd. H2019-101
6 · The paper itself

Abstract

objectiveThis study aimed to identify a relatively robust SUV for guiding clinical practice through quantitative measurement and comparison of various normalization methods based on the SUV of

methodsBetween June 2017 and September 2019, a total of 500 oncology patients (mean age, 60.9; men, 66.0%) who underwent bone SPECT/CT scans with

resultsThe average SUVs in the normal spine and pelvis displayed a relatively wide variability: 4.573 ± 1.972 for SUV

conclusionsThe SUVs of

Indexed as

PelvisSingle Photon Emission Computed Tomography Computed TomographySpineTechnetium Tc 99m MedronateAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesYoung AdultTechnetium Tc 99m Medronate99mTc-methylene diphosphonateBone SPECT/CTPelvisStandardized uptake valueVertebrae

Identifiers

PMID39154304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.